Cargando…

Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice

BACKGROUND: The long-term excessive intake of exogenous cholesterol can lead to abnormally elevated blood lipid levels and induce cardiovascular and cerebrovascular diseases. However, the influence and relevance of exogenous cholesterol on plasma cholesterol components were still unclear, and the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xichao, Ding, Xue, Feng, Han, Bi, Yunhui, Li, Yu, Shan, Jinjun, Bian, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105390/
https://www.ncbi.nlm.nih.gov/pubmed/37061692
http://dx.doi.org/10.1186/s12944-023-01810-6
_version_ 1785026200905711616
author Yu, Xichao
Ding, Xue
Feng, Han
Bi, Yunhui
Li, Yu
Shan, Jinjun
Bian, Huimin
author_facet Yu, Xichao
Ding, Xue
Feng, Han
Bi, Yunhui
Li, Yu
Shan, Jinjun
Bian, Huimin
author_sort Yu, Xichao
collection PubMed
description BACKGROUND: The long-term excessive intake of exogenous cholesterol can lead to abnormally elevated blood lipid levels and induce cardiovascular and cerebrovascular diseases. However, the influence and relevance of exogenous cholesterol on plasma cholesterol components were still unclear, and the influence on intestinal lipid metabolism targets needs to be further explored. METHODS: In vivo, the C57BL/6 + NF group and ApoE(−/−) + NF group mice were fed a normal specific pathogen-free (SPF) diet; the ApoE(−/−) + HF group mice were fed a high-cholesterol SPF diet. The plasma and jejunum tissue homogenate were obtained for non-targeted lipid metabolomics. The lipid droplets in tissues were observed by transmission electron microscope and oil red O staining. Jejunum tissue morphology was observed by HE staining. The kits were used to detect lipid content in plasma, tissues, intestinal contents, and cells. Western blot, RT-PCR, immunohistochemistry (IHC), and immunofluorescence (IF) were used to observe the key target of lipid metabolism. In vitro, the final concentration of cholesterol was 100 μmol/L in Caco-cells. Oil red O staining, western blot, RT-PCR and immunofluorescence (IF) were used to observe the changes of lipid metabolism. Finally, the influence of liver X receptor alpha (LXRα) on intestinal cholesterol metabolism was clarified by applying the LXRα inhibitor GSK2033 and siRNA targeting LXRα. RESULTS: The aortic arch and intestinal villi of the two groups of ApoE(−/−) mice showed apparent lesions and lipid accumulation, and there were significant changes in a variety of lipids in the plasma and jejunum. Additionally, jejunum LXRα was markedly activated. High cholesterol can significantly activate LXRα in Caco-2 cells. After LXRα was inhibited, the protein level of ATP-binding cassette transporter A1/G5/G8 (ABCA1/G5/G8) decreased, and the quantity and volume of intracellular lipids soared. CONCLUSION: In a high-cholesterol environment, the intestine promotes the excretion of cholesterol from the cell through the LXRα-ABCA1/G5/G8 pathway, reduces the intestinal intake of a variety of exogenous cholesterol, and reduces the risk of AS. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01810-6.
format Online
Article
Text
id pubmed-10105390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101053902023-04-16 Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice Yu, Xichao Ding, Xue Feng, Han Bi, Yunhui Li, Yu Shan, Jinjun Bian, Huimin Lipids Health Dis Research BACKGROUND: The long-term excessive intake of exogenous cholesterol can lead to abnormally elevated blood lipid levels and induce cardiovascular and cerebrovascular diseases. However, the influence and relevance of exogenous cholesterol on plasma cholesterol components were still unclear, and the influence on intestinal lipid metabolism targets needs to be further explored. METHODS: In vivo, the C57BL/6 + NF group and ApoE(−/−) + NF group mice were fed a normal specific pathogen-free (SPF) diet; the ApoE(−/−) + HF group mice were fed a high-cholesterol SPF diet. The plasma and jejunum tissue homogenate were obtained for non-targeted lipid metabolomics. The lipid droplets in tissues were observed by transmission electron microscope and oil red O staining. Jejunum tissue morphology was observed by HE staining. The kits were used to detect lipid content in plasma, tissues, intestinal contents, and cells. Western blot, RT-PCR, immunohistochemistry (IHC), and immunofluorescence (IF) were used to observe the key target of lipid metabolism. In vitro, the final concentration of cholesterol was 100 μmol/L in Caco-cells. Oil red O staining, western blot, RT-PCR and immunofluorescence (IF) were used to observe the changes of lipid metabolism. Finally, the influence of liver X receptor alpha (LXRα) on intestinal cholesterol metabolism was clarified by applying the LXRα inhibitor GSK2033 and siRNA targeting LXRα. RESULTS: The aortic arch and intestinal villi of the two groups of ApoE(−/−) mice showed apparent lesions and lipid accumulation, and there were significant changes in a variety of lipids in the plasma and jejunum. Additionally, jejunum LXRα was markedly activated. High cholesterol can significantly activate LXRα in Caco-2 cells. After LXRα was inhibited, the protein level of ATP-binding cassette transporter A1/G5/G8 (ABCA1/G5/G8) decreased, and the quantity and volume of intracellular lipids soared. CONCLUSION: In a high-cholesterol environment, the intestine promotes the excretion of cholesterol from the cell through the LXRα-ABCA1/G5/G8 pathway, reduces the intestinal intake of a variety of exogenous cholesterol, and reduces the risk of AS. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01810-6. BioMed Central 2023-04-15 /pmc/articles/PMC10105390/ /pubmed/37061692 http://dx.doi.org/10.1186/s12944-023-01810-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yu, Xichao
Ding, Xue
Feng, Han
Bi, Yunhui
Li, Yu
Shan, Jinjun
Bian, Huimin
Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title_full Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title_fullStr Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title_full_unstemmed Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title_short Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE(−/−) mice
title_sort excessive exogenous cholesterol activating intestinal lxrα-abca1/g5/g8 signaling pathway can not reverse atherosclerosis in apoe(−/−) mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105390/
https://www.ncbi.nlm.nih.gov/pubmed/37061692
http://dx.doi.org/10.1186/s12944-023-01810-6
work_keys_str_mv AT yuxichao excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT dingxue excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT fenghan excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT biyunhui excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT liyu excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT shanjinjun excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice
AT bianhuimin excessiveexogenouscholesterolactivatingintestinallxraabca1g5g8signalingpathwaycannotreverseatherosclerosisinapoemice